Tools
Stock profile

Progyny, Inc. (PGNY)

PGNY · Latest close $36.16 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$36.16
As of Nov 18, 2026
Tracked funds holding
2 of 149
2026 Q2 13F filings
Opened / added
0 / 2
vs previous quarter
Trimmed / exited
0
vs previous quarter

Progyny, Inc. (PGNY) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds adding versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $22.4M sold). Latest close $36.16 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 11, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-22.4M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Disciplined Growth Investors · First Eagle Investment Management — 2 tracked funds hold PGNY. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 16 sales ($22.4M). Insider trading

Often held alongside

Sotera Health Co (SHC) · Fresenius Medical Care AG (FMS) · agilon health, inc. (AGL) · DAVITA INC. (DVA) · VIEMED HEALTHCARE, INC. (VMD) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Disciplined Growth Investors0.58%1,181,632ADDED (+105.7%) Q3 filed Nov 16
First Eagle Investment Management0.01%213,212ADDED (+8.4%) Q3 filed Nov 10

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +24.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

37.1512.732024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding310 of 8,857 filers
Long-only filers among them309
Change vs 2026 Q1+19 net · 300 entered · 281 exited
Shares reported, all filers78,938,626
Reported value, all filers$2.2B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryServices-Misc Health & Allied Services, NEC (SIC 8090)
Revenue · FY2025$1.3B
Net income · FY2025$58.5M
Total assets · FY2025$742.4M
Shares outstanding76,726,798
Market cap (at latest close)$2.8B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 20264,849,079
Share of shares outstanding6.32%
Days to cover4.24

Shares short at recent settlements — Jul 31, 2026: 4.5M · Aug 14, 2026: 4.6M · Aug 31, 2026: 4.5M · Sep 15, 2026: 4.7M · Sep 30, 2026: 5.1M · Oct 15, 2026: 4.8M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 1K · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 16 sales by 7 insiders ($22.4M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 11, 2026Clapp GeoffreyChief Product OfficerSell774$36.41$28.2KSEC filing
Nov 10, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell120,213$35.61$4.3MSEC filing
Nov 10, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell64,921$36.29$2.4MSEC filing
Nov 10, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell33,437$35.61$1.2MSEC filing
Nov 10, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell18,059$36.29$655.3KSEC filing
Nov 10, 2026Schlanger David JExecutive ChairmanSell35,392$35.36$1.3MSEC filing
Nov 9, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell126,204$35.73$4.5MSEC filing
Nov 9, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell35,104$35.73$1.3MSEC filing
Nov 9, 2026Schlanger David JExecutive ChairmanSell161,208$35.73$5.8MSEC filing
Nov 5, 2026Anevski PeterCHIEF EXECUTIVE OFFICERSell3,400$35.23$119.8KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 23, 2026Swartz AllisonOfficer3,903$101.9KSep 23, 2026SEC filing
Sep 10, 2026GORDON KEVIN KDirector11,500$311.9KSep 10, 2026SEC filing
Jul 14, 2026Cummings Melissa BOfficer2,244$70.9KJul 14, 2026SEC filing
Jun 4, 2026Livingston Mark S.Officer2,517$64.2KJun 4, 2026SEC filing
Jun 4, 2026Swartz AllisonOfficer599$15.0KJun 4, 2026SEC filing
Jun 3, 2026Swartz AllisonOfficer1,199$30.0KJun 3, 2026SEC filing
Jun 2, 2026Clapp GeoffreyOfficer1,530$39.1KJun 2, 2026SEC filing
Jun 2, 2026Livingston Mark S.Officer279$7.3KJun 2, 2026SEC filing
Jun 1, 2026Scott CherylDirector7,439$196.3KJun 1, 2026SEC filing
May 28, 2026Swartz AllisonOfficer2,398$61.1KMay 28, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 6, 2026FMR LLCSC 13G/A7,004,279.538.9%Jun 30, 2026SEC filing
Jun 8, 2026KLEINER PERKINS CAUFIELD & BYERS XIII, LLCSC 13G/A00.0%Mar 31, 2025SEC filing
Apr 29, 2026Vanguard Portfolio ManagementSC 13G5,357,3116.5%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Nov 5, 2025FMR LLCSC 13G/A6,569,099.447.6%Sep 30, 2025SEC filing
Aug 6, 2025FMR LLCSC 13G4,712,613.445.5%Jun 30, 2025SEC filing
Jul 29, 2025The Vanguard GroupSC 13G/A9,870,63411.5%Jun 30, 2025SEC filing
May 14, 2025TPG GP A, LLCSC 13G/A00.0%Mar 31, 2025SEC filing
Apr 29, 2025THRIVENT FINANCIAL FOR LUTHERANSSC 13G5,350,8696.3%Mar 31, 2025SEC filing
Apr 28, 2025BlackRock, Inc.SC 13G/A11,153,24213.0%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Services-Misc Health & Allied Services, NEC (SIC 8090). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Graham — Sound finances and a long run of profits

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· 52-Week High — Recently printed a new 52-week high

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Growth — Latest revenue: $1.3B · 5-yr revenue CAGR: 30.2% · Straight growth years: 5

· Graham — Current ratio: 2.73 · Straight profitable years: 6 · Debt ratio: 0.44 · Latest net income: $58.5M

· Cash Flow (FCF) — Latest FCF: $191.8M · FCF yield: 7.6% · Positive FCF years: 3

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 3.31 · Operating cash flow: $210.2M · Net income: $58.5M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2024 Q4, ranked #27 of 50.

Also held by the tracked funds that hold PGNY — ranked by lift, the co-holding pattern described in Methodology: Sotera Health Co (SHC) · Fresenius Medical Care AG (FMS) · agilon health, inc. (AGL) · DAVITA INC. (DVA) · VIEMED HEALTHCARE, INC. (VMD) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 4, 20262.02 Results of Operations and Financial Condition · 7.01 Regulation FD DisclosureSEC filing
Aug 6, 20262.02 Results of Operations and Financial Condition · 7.01 Regulation FD DisclosureSEC filing
May 27, 20265.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · 5.07 Submission of Matters to a Vote of Security HoldersSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Sotera Health Co (SHC) · Track Record: how the signals scored · Practice timing on PGNY

One email a week: the week’s new filings and research. Subscribe free

← PGEN  ·  PGR →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.